SPIDA: Surveillance and Proactive Intervention for Dialysis Access

Sponsor
University of Hull (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01391975
Collaborator
(none)
0
1
2

Study Details

Study Description

Brief Summary

Newly formed dialysis fistulae can often fail, and failure is usually due to narrowing of the blood vessels. Methods of detecting narrowing are available and, more importantly, can detect narrowings before a fistula fails. It is not known whether treating these narrowings will actually improve fistula survival or if the majority can be left alone. we wish to see if we can detect such narrowings with ultrasound scanning and if early detection and treatment improves patient outcomes.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Active ultrasound surveillance of fistula and proactive treatment of stenosis
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Multi Centre Randomized Controlled Trial of the Clinical and Cost Effectiveness of Duplex Ultrasound Surveillance With Proactive Intervention Versus no Surveillance and Reactive Intervention for the Management of Stenosis in Arterio-venous Fistulae for Dialysis Vascular Access.

Arms and Interventions

Arm Intervention/Treatment
Experimental: Surveillance and proactive intervention

Procedure: Active ultrasound surveillance of fistula and proactive treatment of stenosis
Regular duplex ultrasound assessment of fistula from time of creation until 6 months post procedure with referral of all haemodynamically significant stenoses to further imaging and treatment

No Intervention: Control and reactive intervention

Outcome Measures

Primary Outcome Measures

  1. Cumulative or secondary patency [within 6 months of fistula formation]

    This being the interval from the time of access placement until access abandonment, thrombosis, or the time of patency measurement including intervening manipulations (surgical or endovascular interventions) designed to re-establish functionality in thrombosed access.

Secondary Outcome Measures

  1. Number of thrombosis events [within 6 months of fistula formation]

  2. Number of fistula failures [within 6 months of fistula formation]

  3. Number, type and technical success rate for elective interventions [within 6 months of fistula formation]

  4. Number, type and technical success rate of acute interventions [within 6 months of fistula formation]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Incident patients referred to vascular or transplant surgery departments for primary AV fistula formation for haemodialysis access.

  2. Ability to give informed written consent

  3. Aged over 18 at time of referral

Exclusion Criteria:
  1. Inability to give informed written consent

  2. Aged under 18 at time of referral

  3. Inability to attend follow-up appointments

Specific exclusion;

  1. Previous arteriovenous access procedures in target limb

  2. Unsuitable for upper limb radiocephalic or brachiocephalic AVF formation

  3. Known thrombophilic or thrombotic pathology

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hull Royal Infirmary Hull United Kingdom HU3 2JZ

Sponsors and Collaborators

  • University of Hull

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Hull
ClinicalTrials.gov Identifier:
NCT01391975
Other Study ID Numbers:
  • Access 6
First Posted:
Jul 12, 2011
Last Update Posted:
Mar 22, 2021
Last Verified:
Mar 1, 2021
Keywords provided by University of Hull
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 22, 2021